» Articles » PMID: 11279497

Endogenous Cannabinoids Mediate Retrograde Signalling at Hippocampal Synapses

Overview
Journal Nature
Specialty Science
Date 2001 Mar 30
PMID 11279497
Citations 652
Authors
Affiliations
Soon will be listed here.
Abstract

Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1), which is expressed throughout the brain at high levels. Two endogenous lipids, anandamide and 2-arachidonylglycerol (2-AG), have been identified as CB1 ligands. Depolarized hippocampal neurons rapidly release both anandamide and 2-AG in a Ca2+-dependent manner. In the hippocampus, CB1 is expressed mainly by GABA (gamma-aminobutyric acid)-mediated inhibitory interneurons, where CB1 clusters on the axon terminal. A synthetic CB1 agonist depresses GABA release from hippocampal slices. These findings indicate that the function of endogenous cannabinoids released by depolarized hippocampal neurons might be to downregulate GABA release. Here we show that the transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids. Signalling by the endocannabinoid system thus represents a mechanism by which neurons can communicate backwards across synapses to modulate their inputs.

Citing Articles

Inhibitory and disinhibitory VIP IN-mediated circuits in neocortex.

Dellal S, Zurita H, Valero M, Abad-Perez P, Kruglikov I, Meng J bioRxiv. 2025; .

PMID: 40060562 PMC: 11888407. DOI: 10.1101/2025.02.26.640383.


The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles.

Straub V, Barti B, Tandar S, Stevens A, van Egmond N, van der Wel T Proc Natl Acad Sci U S A. 2025; 122(8):e2421717122.

PMID: 39977325 PMC: 11873938. DOI: 10.1073/pnas.2421717122.


Synaptic Targets and Cellular Sources of CB1 Cannabinoid Receptor and Vesicular Glutamate Transporter-3 Expressing Nerve Terminals in Relation to GABAergic Neurons in the Human Cerebral Cortex.

Somogyi P, Horie S, Lukacs I, Hunter E, Sarkany B, Viney T Eur J Neurosci. 2025; 61(1):e16652.

PMID: 39810425 PMC: 11733414. DOI: 10.1111/ejn.16652.


Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.

Kumar U Int J Mol Sci. 2025; 26(1.

PMID: 39796008 PMC: 11720483. DOI: 10.3390/ijms26010152.


Selective Enhancement of the Interneuron Network and Gamma-Band Power via GluN2C/GluN2D NMDA Receptor Potentiation.

Camp C, Banke T, Xing H, Yu K, Perszyk R, Epplin M bioRxiv. 2024; .

PMID: 39574703 PMC: 11580944. DOI: 10.1101/2024.11.05.622179.